Founded in 2013, JSC „Imunodiagnostika“ focuses on development and production of innovative in-vitro diagnostics solutions in the field of immunology. Our aim is to make diagnostics simple, efficient, accurate and personalized. Our R&D department is currently working on new diagnostics systems based on microarray technology. It is being done in close cooperation with Allergomedica clinic, owned by JSC „Imunodiagnostika“, that specializes exclusively in the diagnosis and treatment of allergic and immunological diseases. During the COVID-19 pandemic we leveraged our extensive knowledge of immunodiagnostics in developing innovative quantative SARS-CoV-2 antibody test kits.